nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Photoabsorption—Methoxsalen—hematologic cancer	0.436	0.5	CiPCiCtD
Verteporfin—Photosensitizing Activity—Methoxsalen—hematologic cancer	0.436	0.5	CiPCiCtD
Verteporfin—Visual impairment—Methotrexate—hematologic cancer	2.17e-05	0.00017	CcSEcCtD
Verteporfin—Anaemia—Prednisone—hematologic cancer	2.17e-05	0.00017	CcSEcCtD
Verteporfin—Headache—Carmustine—hematologic cancer	2.17e-05	0.00017	CcSEcCtD
Verteporfin—Shock—Dexamethasone—hematologic cancer	2.16e-05	0.00017	CcSEcCtD
Verteporfin—Shock—Betamethasone—hematologic cancer	2.16e-05	0.00017	CcSEcCtD
Verteporfin—Dyspnoea—Triamcinolone—hematologic cancer	2.16e-05	0.000169	CcSEcCtD
Verteporfin—Rash—Alitretinoin—hematologic cancer	2.16e-05	0.000169	CcSEcCtD
Verteporfin—Nervous system disorder—Betamethasone—hematologic cancer	2.16e-05	0.000169	CcSEcCtD
Verteporfin—Nervous system disorder—Dexamethasone—hematologic cancer	2.16e-05	0.000169	CcSEcCtD
Verteporfin—Dermatitis—Alitretinoin—hematologic cancer	2.16e-05	0.000169	CcSEcCtD
Verteporfin—Hypersensitivity—Cisplatin—hematologic cancer	2.15e-05	0.000168	CcSEcCtD
Verteporfin—Headache—Alitretinoin—hematologic cancer	2.15e-05	0.000168	CcSEcCtD
Verteporfin—Nausea—Thalidomide—hematologic cancer	2.14e-05	0.000168	CcSEcCtD
Verteporfin—Rash—Ifosfamide—hematologic cancer	2.13e-05	0.000167	CcSEcCtD
Verteporfin—Dermatitis—Ifosfamide—hematologic cancer	2.13e-05	0.000167	CcSEcCtD
Verteporfin—Hyperhidrosis—Dexamethasone—hematologic cancer	2.13e-05	0.000167	CcSEcCtD
Verteporfin—Hyperhidrosis—Betamethasone—hematologic cancer	2.13e-05	0.000167	CcSEcCtD
Verteporfin—Dizziness—Irinotecan—hematologic cancer	2.13e-05	0.000167	CcSEcCtD
Verteporfin—Urticaria—Etoposide—hematologic cancer	2.12e-05	0.000166	CcSEcCtD
Verteporfin—Haemoglobin—Epirubicin—hematologic cancer	2.12e-05	0.000166	CcSEcCtD
Verteporfin—Malaise—Prednisone—hematologic cancer	2.12e-05	0.000166	CcSEcCtD
Verteporfin—Body temperature increased—Etoposide—hematologic cancer	2.11e-05	0.000166	CcSEcCtD
Verteporfin—Conjunctivitis—Doxorubicin—hematologic cancer	2.11e-05	0.000166	CcSEcCtD
Verteporfin—Vertigo—Prednisone—hematologic cancer	2.11e-05	0.000165	CcSEcCtD
Verteporfin—Haemorrhage—Epirubicin—hematologic cancer	2.11e-05	0.000165	CcSEcCtD
Verteporfin—Eye disorder—Methotrexate—hematologic cancer	2.11e-05	0.000165	CcSEcCtD
Verteporfin—Syncope—Prednisone—hematologic cancer	2.11e-05	0.000165	CcSEcCtD
Verteporfin—Hypoaesthesia—Epirubicin—hematologic cancer	2.1e-05	0.000164	CcSEcCtD
Verteporfin—Urticaria—Prednisolone—hematologic cancer	2.09e-05	0.000164	CcSEcCtD
Verteporfin—Asthenia—Cisplatin—hematologic cancer	2.09e-05	0.000164	CcSEcCtD
Verteporfin—Pharyngitis—Epirubicin—hematologic cancer	2.09e-05	0.000164	CcSEcCtD
Verteporfin—Cardiac disorder—Methotrexate—hematologic cancer	2.09e-05	0.000164	CcSEcCtD
Verteporfin—Sweating—Doxorubicin—hematologic cancer	2.08e-05	0.000163	CcSEcCtD
Verteporfin—Rash—Vincristine—hematologic cancer	2.08e-05	0.000163	CcSEcCtD
Verteporfin—Dermatitis—Vincristine—hematologic cancer	2.08e-05	0.000163	CcSEcCtD
Verteporfin—Pain—Triamcinolone—hematologic cancer	2.07e-05	0.000163	CcSEcCtD
Verteporfin—Headache—Vincristine—hematologic cancer	2.07e-05	0.000162	CcSEcCtD
Verteporfin—Loss of consciousness—Prednisone—hematologic cancer	2.06e-05	0.000162	CcSEcCtD
Verteporfin—Nausea—Carmustine—hematologic cancer	2.05e-05	0.000161	CcSEcCtD
Verteporfin—Angiopathy—Methotrexate—hematologic cancer	2.04e-05	0.00016	CcSEcCtD
Verteporfin—Immune system disorder—Methotrexate—hematologic cancer	2.04e-05	0.00016	CcSEcCtD
Verteporfin—Nausea—Alitretinoin—hematologic cancer	2.03e-05	0.000159	CcSEcCtD
Verteporfin—Visual impairment—Epirubicin—hematologic cancer	2.03e-05	0.000159	CcSEcCtD
Verteporfin—Hypertension—Prednisone—hematologic cancer	2.03e-05	0.000159	CcSEcCtD
Verteporfin—Rash—Mitoxantrone—hematologic cancer	2.03e-05	0.000159	CcSEcCtD
Verteporfin—Rash—Irinotecan—hematologic cancer	2.03e-05	0.000159	CcSEcCtD
Verteporfin—Dermatitis—Irinotecan—hematologic cancer	2.02e-05	0.000159	CcSEcCtD
Verteporfin—Dermatitis—Mitoxantrone—hematologic cancer	2.02e-05	0.000159	CcSEcCtD
Verteporfin—Headache—Mitoxantrone—hematologic cancer	2.01e-05	0.000158	CcSEcCtD
Verteporfin—Headache—Irinotecan—hematologic cancer	2.01e-05	0.000158	CcSEcCtD
Verteporfin—Nausea—Ifosfamide—hematologic cancer	2.01e-05	0.000158	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2e-05	0.000157	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2e-05	0.000157	CcSEcCtD
Verteporfin—Arthralgia—Prednisone—hematologic cancer	2e-05	0.000157	CcSEcCtD
Verteporfin—Feeling abnormal—Triamcinolone—hematologic cancer	2e-05	0.000157	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.98e-05	0.000156	CcSEcCtD
Verteporfin—Discomfort—Prednisone—hematologic cancer	1.97e-05	0.000155	CcSEcCtD
Verteporfin—Rash—Gemcitabine—hematologic cancer	1.97e-05	0.000155	CcSEcCtD
Verteporfin—Dermatitis—Gemcitabine—hematologic cancer	1.97e-05	0.000155	CcSEcCtD
Verteporfin—Eye disorder—Epirubicin—hematologic cancer	1.97e-05	0.000154	CcSEcCtD
Verteporfin—Hypersensitivity—Etoposide—hematologic cancer	1.97e-05	0.000154	CcSEcCtD
Verteporfin—Malnutrition—Methotrexate—hematologic cancer	1.96e-05	0.000154	CcSEcCtD
Verteporfin—Haemoglobin—Doxorubicin—hematologic cancer	1.96e-05	0.000154	CcSEcCtD
Verteporfin—Headache—Gemcitabine—hematologic cancer	1.96e-05	0.000154	CcSEcCtD
Verteporfin—Nausea—Vincristine—hematologic cancer	1.96e-05	0.000154	CcSEcCtD
Verteporfin—Cardiac disorder—Epirubicin—hematologic cancer	1.96e-05	0.000153	CcSEcCtD
Verteporfin—Flushing—Epirubicin—hematologic cancer	1.96e-05	0.000153	CcSEcCtD
Verteporfin—Haemorrhage—Doxorubicin—hematologic cancer	1.95e-05	0.000153	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisolone—hematologic cancer	1.94e-05	0.000152	CcSEcCtD
Verteporfin—Hypoaesthesia—Doxorubicin—hematologic cancer	1.94e-05	0.000152	CcSEcCtD
Verteporfin—Pharyngitis—Doxorubicin—hematologic cancer	1.94e-05	0.000152	CcSEcCtD
Verteporfin—Urticaria—Triamcinolone—hematologic cancer	1.93e-05	0.000151	CcSEcCtD
Verteporfin—Asthenia—Etoposide—hematologic cancer	1.92e-05	0.00015	CcSEcCtD
Verteporfin—Body temperature increased—Triamcinolone—hematologic cancer	1.92e-05	0.00015	CcSEcCtD
Verteporfin—Oedema—Prednisone—hematologic cancer	1.92e-05	0.00015	CcSEcCtD
Verteporfin—Angiopathy—Epirubicin—hematologic cancer	1.91e-05	0.00015	CcSEcCtD
Verteporfin—Nausea—Irinotecan—hematologic cancer	1.91e-05	0.00015	CcSEcCtD
Verteporfin—Nausea—Mitoxantrone—hematologic cancer	1.91e-05	0.00015	CcSEcCtD
Verteporfin—Immune system disorder—Epirubicin—hematologic cancer	1.9e-05	0.000149	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.9e-05	0.000149	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.9e-05	0.000149	CcSEcCtD
Verteporfin—Back pain—Methotrexate—hematologic cancer	1.9e-05	0.000149	CcSEcCtD
Verteporfin—Pruritus—Etoposide—hematologic cancer	1.89e-05	0.000148	CcSEcCtD
Verteporfin—Shock—Prednisone—hematologic cancer	1.88e-05	0.000148	CcSEcCtD
Verteporfin—Pain—Dexamethasone—hematologic cancer	1.88e-05	0.000147	CcSEcCtD
Verteporfin—Pain—Betamethasone—hematologic cancer	1.88e-05	0.000147	CcSEcCtD
Verteporfin—Visual impairment—Doxorubicin—hematologic cancer	1.88e-05	0.000147	CcSEcCtD
Verteporfin—Nervous system disorder—Prednisone—hematologic cancer	1.88e-05	0.000147	CcSEcCtD
Verteporfin—Skin disorder—Prednisone—hematologic cancer	1.86e-05	0.000146	CcSEcCtD
Verteporfin—Nausea—Gemcitabine—hematologic cancer	1.86e-05	0.000146	CcSEcCtD
Verteporfin—Hyperhidrosis—Prednisone—hematologic cancer	1.85e-05	0.000145	CcSEcCtD
Verteporfin—Vision blurred—Methotrexate—hematologic cancer	1.85e-05	0.000145	CcSEcCtD
Verteporfin—Rash—Cisplatin—hematologic cancer	1.84e-05	0.000144	CcSEcCtD
Verteporfin—Dermatitis—Cisplatin—hematologic cancer	1.84e-05	0.000144	CcSEcCtD
Verteporfin—Malnutrition—Epirubicin—hematologic cancer	1.84e-05	0.000144	CcSEcCtD
Verteporfin—Eye disorder—Doxorubicin—hematologic cancer	1.82e-05	0.000143	CcSEcCtD
Verteporfin—Ill-defined disorder—Methotrexate—hematologic cancer	1.82e-05	0.000143	CcSEcCtD
Verteporfin—Anaemia—Methotrexate—hematologic cancer	1.81e-05	0.000142	CcSEcCtD
Verteporfin—Feeling abnormal—Betamethasone—hematologic cancer	1.81e-05	0.000142	CcSEcCtD
Verteporfin—Feeling abnormal—Dexamethasone—hematologic cancer	1.81e-05	0.000142	CcSEcCtD
Verteporfin—Cardiac disorder—Doxorubicin—hematologic cancer	1.81e-05	0.000142	CcSEcCtD
Verteporfin—Flushing—Doxorubicin—hematologic cancer	1.81e-05	0.000142	CcSEcCtD
Verteporfin—Hypersensitivity—Triamcinolone—hematologic cancer	1.79e-05	0.00014	CcSEcCtD
Verteporfin—Back pain—Epirubicin—hematologic cancer	1.78e-05	0.000139	CcSEcCtD
Verteporfin—Angiopathy—Doxorubicin—hematologic cancer	1.77e-05	0.000139	CcSEcCtD
Verteporfin—Malaise—Methotrexate—hematologic cancer	1.77e-05	0.000139	CcSEcCtD
Verteporfin—Dizziness—Etoposide—hematologic cancer	1.77e-05	0.000139	CcSEcCtD
Verteporfin—Immune system disorder—Doxorubicin—hematologic cancer	1.76e-05	0.000138	CcSEcCtD
Verteporfin—Vertigo—Methotrexate—hematologic cancer	1.76e-05	0.000138	CcSEcCtD
Verteporfin—Urticaria—Betamethasone—hematologic cancer	1.75e-05	0.000137	CcSEcCtD
Verteporfin—Urticaria—Dexamethasone—hematologic cancer	1.75e-05	0.000137	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.75e-05	0.000137	CcSEcCtD
Verteporfin—Dizziness—Prednisolone—hematologic cancer	1.74e-05	0.000137	CcSEcCtD
Verteporfin—Asthenia—Triamcinolone—hematologic cancer	1.74e-05	0.000136	CcSEcCtD
Verteporfin—Body temperature increased—Betamethasone—hematologic cancer	1.74e-05	0.000136	CcSEcCtD
Verteporfin—Body temperature increased—Dexamethasone—hematologic cancer	1.74e-05	0.000136	CcSEcCtD
Verteporfin—Nausea—Cisplatin—hematologic cancer	1.73e-05	0.000136	CcSEcCtD
Verteporfin—Vision blurred—Epirubicin—hematologic cancer	1.73e-05	0.000136	CcSEcCtD
Verteporfin—Pruritus—Triamcinolone—hematologic cancer	1.72e-05	0.000134	CcSEcCtD
Verteporfin—Cough—Methotrexate—hematologic cancer	1.71e-05	0.000134	CcSEcCtD
Verteporfin—Ill-defined disorder—Epirubicin—hematologic cancer	1.7e-05	0.000134	CcSEcCtD
Verteporfin—Malnutrition—Doxorubicin—hematologic cancer	1.7e-05	0.000133	CcSEcCtD
Verteporfin—Anaemia—Epirubicin—hematologic cancer	1.7e-05	0.000133	CcSEcCtD
Verteporfin—Rash—Etoposide—hematologic cancer	1.69e-05	0.000132	CcSEcCtD
Verteporfin—Dermatitis—Etoposide—hematologic cancer	1.68e-05	0.000132	CcSEcCtD
Verteporfin—Headache—Etoposide—hematologic cancer	1.67e-05	0.000131	CcSEcCtD
Verteporfin—Arthralgia—Methotrexate—hematologic cancer	1.67e-05	0.000131	CcSEcCtD
Verteporfin—Chest pain—Methotrexate—hematologic cancer	1.67e-05	0.000131	CcSEcCtD
Verteporfin—Rash—Prednisolone—hematologic cancer	1.66e-05	0.00013	CcSEcCtD
Verteporfin—Dermatitis—Prednisolone—hematologic cancer	1.66e-05	0.00013	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.66e-05	0.00013	CcSEcCtD
Verteporfin—Malaise—Epirubicin—hematologic cancer	1.66e-05	0.00013	CcSEcCtD
Verteporfin—Headache—Prednisolone—hematologic cancer	1.65e-05	0.000129	CcSEcCtD
Verteporfin—Discomfort—Methotrexate—hematologic cancer	1.65e-05	0.000129	CcSEcCtD
Verteporfin—Vertigo—Epirubicin—hematologic cancer	1.65e-05	0.000129	CcSEcCtD
Verteporfin—Syncope—Epirubicin—hematologic cancer	1.65e-05	0.000129	CcSEcCtD
Verteporfin—Back pain—Doxorubicin—hematologic cancer	1.64e-05	0.000129	CcSEcCtD
Verteporfin—Constipation—Prednisone—hematologic cancer	1.64e-05	0.000128	CcSEcCtD
Verteporfin—Loss of consciousness—Epirubicin—hematologic cancer	1.61e-05	0.000126	CcSEcCtD
Verteporfin—Dizziness—Triamcinolone—hematologic cancer	1.6e-05	0.000126	CcSEcCtD
Verteporfin—Cough—Epirubicin—hematologic cancer	1.6e-05	0.000126	CcSEcCtD
Verteporfin—Vision blurred—Doxorubicin—hematologic cancer	1.6e-05	0.000125	CcSEcCtD
Verteporfin—Nausea—Etoposide—hematologic cancer	1.59e-05	0.000124	CcSEcCtD
Verteporfin—Hypertension—Epirubicin—hematologic cancer	1.59e-05	0.000124	CcSEcCtD
Verteporfin—Feeling abnormal—Prednisone—hematologic cancer	1.58e-05	0.000124	CcSEcCtD
Verteporfin—Asthenia—Dexamethasone—hematologic cancer	1.58e-05	0.000124	CcSEcCtD
Verteporfin—Asthenia—Betamethasone—hematologic cancer	1.58e-05	0.000124	CcSEcCtD
Verteporfin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.58e-05	0.000124	CcSEcCtD
Verteporfin—Nervous system disorder—Methotrexate—hematologic cancer	1.57e-05	0.000123	CcSEcCtD
Verteporfin—Anaemia—Doxorubicin—hematologic cancer	1.57e-05	0.000123	CcSEcCtD
Verteporfin—Nausea—Prednisolone—hematologic cancer	1.57e-05	0.000123	CcSEcCtD
Verteporfin—Arthralgia—Epirubicin—hematologic cancer	1.56e-05	0.000123	CcSEcCtD
Verteporfin—Chest pain—Epirubicin—hematologic cancer	1.56e-05	0.000123	CcSEcCtD
Verteporfin—Pruritus—Dexamethasone—hematologic cancer	1.56e-05	0.000122	CcSEcCtD
Verteporfin—Pruritus—Betamethasone—hematologic cancer	1.56e-05	0.000122	CcSEcCtD
Verteporfin—Skin disorder—Methotrexate—hematologic cancer	1.56e-05	0.000122	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.55e-05	0.000122	CcSEcCtD
Verteporfin—Hyperhidrosis—Methotrexate—hematologic cancer	1.55e-05	0.000121	CcSEcCtD
Verteporfin—Discomfort—Epirubicin—hematologic cancer	1.54e-05	0.000121	CcSEcCtD
Verteporfin—Malaise—Doxorubicin—hematologic cancer	1.53e-05	0.00012	CcSEcCtD
Verteporfin—Rash—Triamcinolone—hematologic cancer	1.53e-05	0.00012	CcSEcCtD
Verteporfin—Dermatitis—Triamcinolone—hematologic cancer	1.53e-05	0.00012	CcSEcCtD
Verteporfin—Vertigo—Doxorubicin—hematologic cancer	1.53e-05	0.00012	CcSEcCtD
Verteporfin—Syncope—Doxorubicin—hematologic cancer	1.52e-05	0.000119	CcSEcCtD
Verteporfin—Urticaria—Prednisone—hematologic cancer	1.52e-05	0.000119	CcSEcCtD
Verteporfin—Headache—Triamcinolone—hematologic cancer	1.52e-05	0.000119	CcSEcCtD
Verteporfin—Body temperature increased—Prednisone—hematologic cancer	1.51e-05	0.000119	CcSEcCtD
Verteporfin—Oedema—Epirubicin—hematologic cancer	1.5e-05	0.000117	CcSEcCtD
Verteporfin—Loss of consciousness—Doxorubicin—hematologic cancer	1.49e-05	0.000117	CcSEcCtD
Verteporfin—Cough—Doxorubicin—hematologic cancer	1.48e-05	0.000116	CcSEcCtD
Verteporfin—Shock—Epirubicin—hematologic cancer	1.47e-05	0.000116	CcSEcCtD
Verteporfin—Nervous system disorder—Epirubicin—hematologic cancer	1.47e-05	0.000115	CcSEcCtD
Verteporfin—Hypertension—Doxorubicin—hematologic cancer	1.47e-05	0.000115	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.46e-05	0.000114	CcSEcCtD
Verteporfin—Skin disorder—Epirubicin—hematologic cancer	1.46e-05	0.000114	CcSEcCtD
Verteporfin—Dizziness—Betamethasone—hematologic cancer	1.45e-05	0.000114	CcSEcCtD
Verteporfin—Dizziness—Dexamethasone—hematologic cancer	1.45e-05	0.000114	CcSEcCtD
Verteporfin—Hyperhidrosis—Epirubicin—hematologic cancer	1.45e-05	0.000114	CcSEcCtD
Verteporfin—Arthralgia—Doxorubicin—hematologic cancer	1.45e-05	0.000113	CcSEcCtD
Verteporfin—Chest pain—Doxorubicin—hematologic cancer	1.45e-05	0.000113	CcSEcCtD
Verteporfin—Nausea—Triamcinolone—hematologic cancer	1.44e-05	0.000113	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.44e-05	0.000113	CcSEcCtD
Verteporfin—Discomfort—Doxorubicin—hematologic cancer	1.43e-05	0.000112	CcSEcCtD
Verteporfin—Dyspnoea—Methotrexate—hematologic cancer	1.43e-05	0.000112	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisone—hematologic cancer	1.41e-05	0.000111	CcSEcCtD
Verteporfin—Rash—Betamethasone—hematologic cancer	1.39e-05	0.000109	CcSEcCtD
Verteporfin—Rash—Dexamethasone—hematologic cancer	1.39e-05	0.000109	CcSEcCtD
Verteporfin—Oedema—Doxorubicin—hematologic cancer	1.39e-05	0.000109	CcSEcCtD
Verteporfin—Dermatitis—Betamethasone—hematologic cancer	1.39e-05	0.000109	CcSEcCtD
Verteporfin—Dermatitis—Dexamethasone—hematologic cancer	1.39e-05	0.000109	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.38e-05	0.000108	CcSEcCtD
Verteporfin—Headache—Dexamethasone—hematologic cancer	1.38e-05	0.000108	CcSEcCtD
Verteporfin—Headache—Betamethasone—hematologic cancer	1.38e-05	0.000108	CcSEcCtD
Verteporfin—Asthenia—Prednisone—hematologic cancer	1.37e-05	0.000108	CcSEcCtD
Verteporfin—Pain—Methotrexate—hematologic cancer	1.37e-05	0.000107	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.37e-05	0.000107	CcSEcCtD
Verteporfin—Shock—Doxorubicin—hematologic cancer	1.36e-05	0.000107	CcSEcCtD
Verteporfin—Nervous system disorder—Doxorubicin—hematologic cancer	1.36e-05	0.000107	CcSEcCtD
Verteporfin—Pruritus—Prednisone—hematologic cancer	1.36e-05	0.000106	CcSEcCtD
Verteporfin—Skin disorder—Doxorubicin—hematologic cancer	1.35e-05	0.000106	CcSEcCtD
Verteporfin—Hyperhidrosis—Doxorubicin—hematologic cancer	1.34e-05	0.000105	CcSEcCtD
Verteporfin—Dyspnoea—Epirubicin—hematologic cancer	1.34e-05	0.000105	CcSEcCtD
Verteporfin—Feeling abnormal—Methotrexate—hematologic cancer	1.32e-05	0.000103	CcSEcCtD
Verteporfin—Nausea—Dexamethasone—hematologic cancer	1.31e-05	0.000102	CcSEcCtD
Verteporfin—Nausea—Betamethasone—hematologic cancer	1.31e-05	0.000102	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.29e-05	0.000101	CcSEcCtD
Verteporfin—Pain—Epirubicin—hematologic cancer	1.28e-05	0.0001	CcSEcCtD
Verteporfin—Constipation—Epirubicin—hematologic cancer	1.28e-05	0.0001	CcSEcCtD
Verteporfin—Urticaria—Methotrexate—hematologic cancer	1.27e-05	9.97e-05	CcSEcCtD
Verteporfin—Dizziness—Prednisone—hematologic cancer	1.27e-05	9.93e-05	CcSEcCtD
Verteporfin—Body temperature increased—Methotrexate—hematologic cancer	1.27e-05	9.92e-05	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.26e-05	9.9e-05	CcSEcCtD
Verteporfin—Dyspnoea—Doxorubicin—hematologic cancer	1.24e-05	9.69e-05	CcSEcCtD
Verteporfin—Feeling abnormal—Epirubicin—hematologic cancer	1.23e-05	9.68e-05	CcSEcCtD
Verteporfin—Rash—Prednisone—hematologic cancer	1.21e-05	9.47e-05	CcSEcCtD
Verteporfin—Dermatitis—Prednisone—hematologic cancer	1.21e-05	9.46e-05	CcSEcCtD
Verteporfin—Headache—Prednisone—hematologic cancer	1.2e-05	9.41e-05	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.2e-05	9.38e-05	CcSEcCtD
Verteporfin—Urticaria—Epirubicin—hematologic cancer	1.19e-05	9.33e-05	CcSEcCtD
Verteporfin—Pain—Doxorubicin—hematologic cancer	1.19e-05	9.29e-05	CcSEcCtD
Verteporfin—Constipation—Doxorubicin—hematologic cancer	1.19e-05	9.29e-05	CcSEcCtD
Verteporfin—Body temperature increased—Epirubicin—hematologic cancer	1.18e-05	9.28e-05	CcSEcCtD
Verteporfin—Hypersensitivity—Methotrexate—hematologic cancer	1.18e-05	9.25e-05	CcSEcCtD
Verteporfin—Asthenia—Methotrexate—hematologic cancer	1.15e-05	9e-05	CcSEcCtD
Verteporfin—Feeling abnormal—Doxorubicin—hematologic cancer	1.14e-05	8.95e-05	CcSEcCtD
Verteporfin—Nausea—Prednisone—hematologic cancer	1.14e-05	8.92e-05	CcSEcCtD
Verteporfin—Pruritus—Methotrexate—hematologic cancer	1.13e-05	8.88e-05	CcSEcCtD
Verteporfin—Hypersensitivity—Epirubicin—hematologic cancer	1.1e-05	8.65e-05	CcSEcCtD
Verteporfin—Urticaria—Doxorubicin—hematologic cancer	1.1e-05	8.63e-05	CcSEcCtD
Verteporfin—Body temperature increased—Doxorubicin—hematologic cancer	1.1e-05	8.59e-05	CcSEcCtD
Verteporfin—Asthenia—Epirubicin—hematologic cancer	1.08e-05	8.43e-05	CcSEcCtD
Verteporfin—Pruritus—Epirubicin—hematologic cancer	1.06e-05	8.31e-05	CcSEcCtD
Verteporfin—Dizziness—Methotrexate—hematologic cancer	1.06e-05	8.3e-05	CcSEcCtD
Verteporfin—Hypersensitivity—Doxorubicin—hematologic cancer	1.02e-05	8.01e-05	CcSEcCtD
Verteporfin—Rash—Methotrexate—hematologic cancer	1.01e-05	7.91e-05	CcSEcCtD
Verteporfin—Dermatitis—Methotrexate—hematologic cancer	1.01e-05	7.91e-05	CcSEcCtD
Verteporfin—Headache—Methotrexate—hematologic cancer	1e-05	7.86e-05	CcSEcCtD
Verteporfin—Asthenia—Doxorubicin—hematologic cancer	9.95e-06	7.8e-05	CcSEcCtD
Verteporfin—Dizziness—Epirubicin—hematologic cancer	9.91e-06	7.77e-05	CcSEcCtD
Verteporfin—Pruritus—Doxorubicin—hematologic cancer	9.81e-06	7.69e-05	CcSEcCtD
Verteporfin—Nausea—Methotrexate—hematologic cancer	9.51e-06	7.45e-05	CcSEcCtD
Verteporfin—Rash—Epirubicin—hematologic cancer	9.45e-06	7.4e-05	CcSEcCtD
Verteporfin—Dermatitis—Epirubicin—hematologic cancer	9.44e-06	7.4e-05	CcSEcCtD
Verteporfin—Headache—Epirubicin—hematologic cancer	9.39e-06	7.36e-05	CcSEcCtD
Verteporfin—Dizziness—Doxorubicin—hematologic cancer	9.17e-06	7.19e-05	CcSEcCtD
Verteporfin—Nausea—Epirubicin—hematologic cancer	8.9e-06	6.98e-05	CcSEcCtD
Verteporfin—Rash—Doxorubicin—hematologic cancer	8.74e-06	6.85e-05	CcSEcCtD
Verteporfin—Dermatitis—Doxorubicin—hematologic cancer	8.73e-06	6.85e-05	CcSEcCtD
Verteporfin—Headache—Doxorubicin—hematologic cancer	8.69e-06	6.81e-05	CcSEcCtD
Verteporfin—Nausea—Doxorubicin—hematologic cancer	8.24e-06	6.45e-05	CcSEcCtD
